Back to discover
Drug

Thyrotropin

Research stage
ClassThyroid stimulating hormone receptor agonistEmerging researchSteady momentum

Also known as TSH - thyroid stimulating hormone, Thyroid stimulating hormone, THYROTROPHIN.

16
Research papers
Thyrotropin receptor
Primary target
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this drug.

Thyroid Hormone Homeostasis in Levothyroxine-treated Patients: Findings From ELSA-Brasil.

Research2024-09-01The Journal of clinical endocrinology and metabolism

Predictors of controlled attenuation parameter in metabolic dysfunction.

Research2023-12-23United European gastroenterology journal

Profile

Identifiers & mechanism

Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.

Canonical name
Thyrotropin
Aliases & brands
TSH - thyroid stimulating hormoneThyroid stimulating hormoneTHYROTROPHIN
RxNorm CUI
10579
ChEMBL ID
CHEMBL1201532
ATC codes
V04CJ01
UNII
02KSI6Z9AK
Primary mechanism
Thyroid stimulating hormone receptor agonist

Pharmacology & targets

1 target

Known molecular targets and mechanisms supported by curated pharmacology databases.

Thyrotropin receptor
TSHR · P16473
AGONISTThyroid stimulating hormone receptor agonist

Research activity

16 papers

Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.

Publications over time
20192025
Most influential
Recent papers
Major research themes8
Hypothyroidism4Thyroid Gland4Thyroxine4Obesity2Thyroid Hormones2Diabetes Mellitus1Diabetes Mellitus, Type 21Elasticity Imaging Techniques1
Journals, researchers & institutions
Top journals
  • Frontiers in endocrinology3
  • Nutrients2
  • Biomolecules1
  • Diabetes/metabolism research and reviews1
  • European journal of endocrinology1
  • Hepatology (Baltimore, Md.)1
Leading researchers
  • Brown SJ2
  • Chaker L2
  • Peeters RP2
  • Walsh JP2
  • A Crimmins N1
  • A Mencin A1
  • A Xanthakos S1
  • Alexander EK1
Leading institutions
free-text, unnormalised
  • Department of Laboratory Medicine3
  • Academic Center for Thyroid Diseases2
  • Harvard Medical School2
  • Institute of Cardiovascular and Medical Sciences2
  • Sir Charles Gairdner Hospital2
  • Algebra University College1

Related diseases

4 conditions

Regulator-approved indications and conditions co-mentioned with this drug across the research literature. Number shows shared papers.

Related drugs

5 matches

Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).

Studied across 9 of the same disease areas as Thyrotropin in the shared literature.

9 shared diseases7 shared papers

Studied across 17 of the same disease areas as Thyrotropin in the shared literature.

17 shared diseases2 shared papers

Studied across 8 of the same disease areas as Thyrotropin in the shared literature.

8 shared diseases5 shared papers

Studied across 6 of the same disease areas as Thyrotropin in the shared literature.

6 shared diseases1 shared paper

Frequently co-studied with Thyrotropin in the research literature.

1 shared paper
References & data sources
  • RxNorm (U.S. National Library of Medicine) — drug identity
  • ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
  • Europe PMC — research literature